Expression of p27 and VHL in renal tumors.

TitleExpression of p27 and VHL in renal tumors.
Publication TypeJournal Article
Year of Publication2002
AuthorsOsipov V, Keating JT, Faul PN, Loda M, Datta MW
JournalAppl Immunohistochem Mol Morphol
Volume10
Issue4
Pagination344-50
Date Published2002 Dec
ISSN1541-2016
KeywordsAdenoma, Oxyphilic, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Cell Cycle, Cell Cycle Proteins, Cell Division, Cyclin-Dependent Kinase Inhibitor p27, Humans, Immunohistochemistry, Kidney Neoplasms, Ligases, Neoplasm Staging, Prognosis, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein
Abstract

Renal tumors, in particular clear cell renal cell carcinomas, have an unclear prognosis and metastatic potential. Cell cycle regulators play a key role in cellular proliferation and have been implicated in neoplasia. The cell cycle inhibitor p27 has been associated with prognosis in various tumor types. Recently a reported association between p27 and Von Hippel-Lindau (VHL) gene function has also been noted. We have examined p27 and VHL expression by immunohistochemistry in a panel of kidney tumors and have noted specific and unique patterns of p27 expression in various tumor types. In addition, we have analyzed p27 expression in clear cell type renal cell carcinomas and have noted a significant association between decreasing p27 expression and increasing tumor size, suggesting a relation between renal cell proliferation and loss of p27 function. These findings suggest a role for p27 in the development of various types of renal tumors.

DOI10.1097/00129039-200212000-00010
Alternate JournalAppl Immunohistochem Mol Morphol
PubMed ID12607603
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700